Home » FDA Clears Hologic’s Automated Platform for Cervical Cancer Cervista HPV Assay
FDA Clears Hologic’s Automated Platform for Cervical Cancer Cervista HPV Assay
FDA approved Hologic’s Cervista HTA (high-throughput automation) system for use with the firm’s already cleared Cervista human papillomavirus (HPV) HR test. The assay uses Hologic’s Invader technology to detect 14 high-risk HPV types associated with cervical cancer and precancerous lesions.
Genetic Engineering & Biotechnology News
Genetic Engineering & Biotechnology News
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May